BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29771690)

  • 1. Heavily Pigmented Epithelioid Melanoma With Loss of Protein Kinase A Regulatory Subunit-α Expression.
    Cohen JN; Spies JA; Ross F; Bohlke A; McCalmont TH
    Am J Dermatopathol; 2018 Dec; 40(12):912-916. PubMed ID: 29771690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic and Clinicopathologic Characteristics of PRKAR1A-inactivated Melanomas: Toward Genetic Distinctions of Animal-type Melanoma/Pigment Synthesizing Melanoma.
    Cohen JN; Yeh I; Mully TW; LeBoit PE; McCalmont TH
    Am J Surg Pathol; 2020 Jun; 44(6):805-816. PubMed ID: 32118628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Analysis of Pigmented Epithelioid Melanocytomas Reveals Recurrent Alterations in PRKAR1A, and PRKCA Genes.
    Cohen JN; Joseph NM; North JP; Onodera C; Zembowicz A; LeBoit PE
    Am J Surg Pathol; 2017 Oct; 41(10):1333-1346. PubMed ID: 28796000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal type melanoma: a report of a case with balloon-cell change and sentinel lymph node metastasis.
    Requena L; de la Cruz A; Moreno C; Sangüeza O; Requena C
    Am J Dermatopathol; 2001 Aug; 23(4):341-6. PubMed ID: 11481528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distant metastasis due to heavily pigmented epithelioid melanoma with underlying BRAF V600E, NOTCH1, ERBB3, and PTEN mutations.
    Motaparthi K; George EV; Guo R
    J Cutan Pathol; 2019 Aug; 46(8):613-618. PubMed ID: 31025390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial Angiomyxomas Frequently Demonstrate Loss of Protein Kinase A Regulatory Subunit 1 Alpha Expression: Immunohistochemical Analysis of 29 Cases and Cutaneous Myxoid Neoplasms With Histopathologic Overlap.
    Neumann NM; LeBoit PE; Cohen JN
    Am J Surg Pathol; 2022 Feb; 46(2):226-232. PubMed ID: 34889853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic Characteristics of Spitz Melanoma With MAP3K8 Fusion or Truncation in a Pediatric Cohort.
    Newman S; Pappo A; Raimondi S; Zhang J; Barnhill R; Bahrami A
    Am J Surg Pathol; 2019 Dec; 43(12):1631-1637. PubMed ID: 31498175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis of heavily pigmented melanocytic lesions: challenges and diagnostic approach.
    Aung PP; Mutyambizi KK; Danialan R; Ivan D; Prieto VG
    J Clin Pathol; 2015 Dec; 68(12):963-70. PubMed ID: 26602414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelioid and fusiform blue nevus of chronically sun-damaged skin, an entity distinct from the epithelioid blue nevus of the Carney complex.
    Yazdan P; Haghighat Z; Guitart J; Gerami P
    Am J Surg Pathol; 2013 Jan; 37(1):81-8. PubMed ID: 22892599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms.
    Williams EA; Shah N; Danziger N; Montesion M; Sokol ES; Pavlick DC; Miller VA; Ross JS; Elvin JA; Tse JY
    J Am Acad Dermatol; 2021 Apr; 84(4):1069-1071. PubMed ID: 32682887
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteogenic Melanoma With Desmin Expression.
    Trevisan F; Tregnago AC; Lopes Pinto CA; Urvanegia ACM; Morbeck DL; Bertolli E; Riva Neto FR; Duprat Neto JP; de Macedo MP
    Am J Dermatopathol; 2017 Jul; 39(7):528-533. PubMed ID: 27655122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epithelioid and hyperpigmented melanocytic tumors. An overview].
    Kutzner H; Schärer L; Requena L
    Pathologe; 2007 Nov; 28(6):411-21. PubMed ID: 17899087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma with prominent pigment synthesis (animal-type melanoma): a case report with ultrastructural studies.
    Kazakov DV; Rütten A; Kempf W; Michal M
    Am J Dermatopathol; 2004 Aug; 26(4):290-7. PubMed ID: 15249859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases.
    Phadke PA; Rakheja D; Le LP; Selim MA; Kapur P; Davis A; Mihm MC; Hoang MP
    Am J Surg Pathol; 2011 May; 35(5):656-69. PubMed ID: 21436676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma associated with a dermatofibroma.
    Kovach BT; Boyd AS
    J Cutan Pathol; 2007 May; 34(5):420-2. PubMed ID: 17448199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vulvar Pigmented Epithelioid Melanocytoma With a Novel HTT-PKN1 Fusion: A Case Report.
    Donati M; Kastnerova L; Cempírková D; Vaněček T; Michal M; Kazakov DV
    Am J Dermatopathol; 2020 Jul; 42(7):544-546. PubMed ID: 31972666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo.
    Tschandl P; Berghoff AS; Preusser M; Pammer J; Pehamberger H; Kittler H
    Br J Dermatol; 2016 Feb; 174(2):364-70. PubMed ID: 26613644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.